Royal Bank of Canada’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-279
| Closed | – | – | 6796 |
|
|
2024
Q2 | $0 | Buy |
279
+58
| +26% | – | ﹤0.01% | 6941 |
|
|
2024
Q1 | $0 | Buy |
221
+90
| +69% | – | ﹤0.01% | 6879 |
|
|
2023
Q4 | $0 | Sell |
131
-6
| -4% | – | ﹤0.01% | 6869 |
|
|
2023
Q3 | $0 | Sell |
137
-341
| -71% | – | ﹤0.01% | 6893 |
|
|
2023
Q2 | $1K | Buy |
+478
| New | +$1K | ﹤0.01% | 6600 |
|
|
2022
Q4 | – | Sell |
-3,084
| Closed | -$4K | – | 7065 |
|
|
2022
Q3 | $4K | Buy |
3,084
+731
| +31% | +$948 | ﹤0.01% | 6331 |
|
|
2022
Q2 | $5K | Buy |
2,353
+998
| +74% | +$2.12K | ﹤0.01% | 6193 |
|
|
2022
Q1 | $9K | Sell |
1,355
-3,513
| -72% | -$23.3K | ﹤0.01% | 6519 |
|
|
2021
Q4 | $61K | Buy |
4,868
+3,097
| +175% | +$38.8K | ﹤0.01% | 5720 |
|
|
2021
Q3 | $162K | Sell |
1,771
-4,594
| -72% | -$420K | ﹤0.01% | 4847 |
|
|
2021
Q2 | $337K | Buy |
6,365
+5,434
| +584% | +$288K | ﹤0.01% | 4170 |
|
|
2021
Q1 | $34K | Buy |
931
+787
| +547% | +$28.7K | ﹤0.01% | 5628 |
|
|
2020
Q4 | $4K | Buy |
144
+117
| +433% | +$3.25K | ﹤0.01% | 6186 |
|
|
2020
Q3 | $1K | Hold |
27
| – | – | ﹤0.01% | 5971 |
|
|
2020
Q2 | $1K | Sell |
27
-24
| -47% | -$889 | ﹤0.01% | 5992 |
|
|
2020
Q1 | $2K | Buy |
+51
| New | +$2K | ﹤0.01% | 5815 |
|
|
2019
Q4 | – | Sell |
-67
| Closed | -$2K | – | 6328 |
|
|
2019
Q3 | $2K | Buy |
+67
| New | +$2K | ﹤0.01% | 5635 |
|